In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews, February 2014

Executive Summary

This Month's Profile Group, Strategic Spin-Outs: Biotech Start-Ups Structure Their Progeny For Success, features profiles of Envisia Therapeutics, f-star Alpha, Onkaido Therapeutics, Seragon Pharmaceuticals, and True North Therapeutics. Plus these Start-Ups Across Health Care: Arecor, Gecko Biomedical, and MediValve.

You may also be interested in...



MediValve Ltd.

Complementing the rapidly growing transcatheter aortic valve implantation (TAVI) market is the acWire from MediValve Ltd., a guidewire specifically designed to accurately place and align medical devices in the cardiovascular system during the minimally invasive TAVI procedure.

Gecko Biomedical

Unlike competing surgical glues used for heart and vascular procedures that offer either strong adhesion or nontoxicity, or both, the liquid glue in development from Gecko Biomedical SAS offers the additional feature of being effective in a wet environment. Gecko’s product, derived from glycol and sebacic acid, is spread at room temperature on the wound in a viscous, pre-polymer state and adheres to tissue when activated by ultraviolet light.

Teladoc Health Acquires Livongo In $18.5Bn Deal, Creating Virtual Care Giant

The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.   

Topics

Related Companies

UsernamePublicRestriction

Register

LL1127945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel